{
    "2020-01-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Lilly Fends Off Sagging Drug Prices To Post Its Best Growth In 2 Years",
                "features": {
                    "keywords": [
                        "drug prices",
                        "best growth",
                        "sagging"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "Lilly's NDA for Selpercatinib Gets FDA's Priority Review",
                "features": {
                    "keywords": [
                        "NDA",
                        "Selpercatinib",
                        "FDA",
                        "priority review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-02-04",
                "original_text": "Lilly (LLY) Q4 Earnings and Sales Top Estimates, Stock Up",
                "features": {
                    "keywords": [
                        "Q4 earnings",
                        "sales top estimates",
                        "stock up"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-03",
                "original_text": "Eli Lilly beats profit estimates on strong demand for diabetes drug Trulicity",
                "features": {
                    "keywords": [
                        "profit estimates",
                        "strong demand",
                        "Trulicity"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-04",
                "original_text": "Eli Lilly Stock Is Climbing After a Glowing Earnings Report",
                "features": {
                    "keywords": [
                        "stock climbing",
                        "earnings report"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-04",
                "original_text": "Eli Lilly (LLY) Tops Q4 Earnings & Sales, Keeps 2020 View",
                "features": {
                    "keywords": [
                        "Q4 earnings",
                        "sales",
                        "2020 view"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2015-12-17",
                "original_text": "Slapping Around Martin Shkreli Wonâ€™t Cut Drug Prices",
                "features": {
                    "keywords": [
                        "Martin Shkreli",
                        "drug prices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "Eli Lilly Earnings Top; Drug Giant Rises",
                "features": {
                    "keywords": [
                        "earnings top",
                        "drug giant rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-05",
                "original_text": "Eli Lilly's stock gains after earnings, revenue rise above expectations",
                "features": {
                    "keywords": [
                        "stock gains",
                        "earnings",
                        "revenue rise"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-04",
                "original_text": "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition",
                "features": {
                    "keywords": [
                        "fourth-quarter",
                        "financial results",
                        "2020 guidance",
                        "Dermira acquisition"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis",
                "features": {
                    "keywords": [
                        "positive top-line",
                        "Phase 3 study",
                        "Baricitinib",
                        "atopic dermatitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-03",
                "original_text": "Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz",
                "features": {
                    "keywords": [
                        "earnings beat",
                        "Trulicity",
                        "Taltz",
                        "strong demand"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-03",
                "original_text": "Stocks - Facebook Slumps, Verizon Slips in Premarket, Tesla Surges",
                "features": {
                    "keywords": [
                        "Facebook",
                        "Verizon",
                        "Tesla",
                        "premarket"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "telecommunications",
                        "automobiles"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}